Stocks
Zymeworks Inc.

Zymeworks Inc.ZYME

NASDAQHealthcareBiotechnology$26.24

Price as of · delayed, not real-time

A clinical-stage biopharmaceutical company developing antibody-drug conjugates and bispecific antibodies for cancer treatment. Its lead candidate, ZW49, targets HER2-positive solid tumors, and the company has partnerships with major pharmaceutical firms. Investors track Zymeworks for its oncology pipeline and potential in the precision medicine space.

52W Range: $18.20-$31.97

Congressional Interest in Zymeworks Inc. (ZYME)

1 member of Congress has disclosed 1 trade in Zymeworks Inc. (ZYME), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1

Who in Congress Is Trading ZYME?

2010-12-10$50K-$100K
Stock